According to Prelude Therapeutics's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -A$0.2 Billion a decrease over its 2022 earnings that were of -A$0.19 Billion. The earnings displayed on this page is the company's Pretax Income.